<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2221-2450</journal-id>
<journal-title><![CDATA[Revista CENIC Ciencias Biológicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. CENIC Cienc. Biol]]></abbrev-journal-title>
<issn>2221-2450</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Investigaciones Científicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2221-24502020000300264</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Dementia post ictus: Is policosanol a prevention therapy?]]></article-title>
<article-title xml:lang="es"><![CDATA[Demencia post ictus: ¿Es útil el policosanol como terapia preventiva?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Illnait Ferrer]]></surname>
<given-names><![CDATA[José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández Travieso]]></surname>
<given-names><![CDATA[Julio César]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reyes Núñez]]></surname>
<given-names><![CDATA[Yenney]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duquesne Chávez]]></surname>
<given-names><![CDATA[Alicia de la Caridad]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,National Center for Scientific Research Clinical Trials Unit ]]></institution>
<addr-line><![CDATA[ Havana]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>51</volume>
<numero>3</numero>
<fpage>264</fpage>
<lpage>271</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2221-24502020000300264&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2221-24502020000300264&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2221-24502020000300264&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Stroke is a global health problem related to various risk factors. Although its frequency is increasing with age, it can also appear in young people. The sequelae observed, after the event, include the presence of motor and cognitive disabling effects, including appearance of dementia, Alzheimer disease and, conditioning the recurrence of stroke episodes, all together constituting a serious socioeconomic problem. Taking into account, on one side, the relationship between lipid metabolism disorders, atherosclerosis, the age of onset of stroke and the development of cognitive decline after the event and on the other, that policosanol, a drug of natural origin, has demonstrated efficacy in the treatment of dyslipidemia (a risk factor commonly present in patients suffering a stroke), as well as on their motor and functional recovery, without showing evidences of cognitive decline during a long period of time after occurring the event, then this paper is aimed to assess a putative role of policosanol in preventing cognitive decline or at least decrease the prevalence of its appearing in such patients. A brief analysis on the molecular basis that would support this hypothesis, is done and is concluded that conducting of appropriates clinical assays is needed to prove the presented hypothesis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  El ictus es un problema de salud global relacionado con varios factores de riesgo. Aunque su frecuencia aumenta con la edad, también puede aparecer en personas jóvenes. Las secuelas observadas, después del evento, incluyen la presencia de efectos de discapacidad motora y cognitiva, incluida la aparición de demencia, enfermedad de Alzheimer y, condicionando la recurrencia de episodios de ictus, todo lo cual constituye un grave problema socioeconómico. Teniendo en cuenta, por un lado, la relación entre los trastornos del metabolismo de los lípidos, la aterosclerosis, la edad del paciente en que se produce el ictus y el desarrollo del deterioro cognitivo después del evento y, por el otro, que el policosanol, un medicamento de origen natural, ha demostrado eficacia en el tratamiento de la dislipidemia (un factor de riesgo comúnmente presente en pacientes que sufren un ictus), así como en su recuperación motora y funcional, sin mostrar evidencias de deterioro cognitivo durante un largo período de tiempo después de su recuperación, el objetivo de este trabajo es analizar el papel que pudiese desempeñar el policosanol en la prevención del deterioro cognitivo o al menos en la disminución de la prevalencia de su aparición en dichos pacientes. Se realiza un breve análisis sobre la base molecular que respaldaría esta hipótesis, y se concluye que se necesita realizar ensayos clínicos apropiados para probar la hipótesis presentada.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Dementia]]></kwd>
<kwd lng="en"><![CDATA[Policosanol]]></kwd>
<kwd lng="en"><![CDATA[Stroke]]></kwd>
<kwd lng="en"><![CDATA[Alzheimer Disease]]></kwd>
<kwd lng="en"><![CDATA[Central Nervous System]]></kwd>
<kwd lng="es"><![CDATA[Demencia]]></kwd>
<kwd lng="es"><![CDATA[Policosanol]]></kwd>
<kwd lng="es"><![CDATA[Ictus]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad de Alzheimer]]></kwd>
<kwd lng="es"><![CDATA[Sistema Nervioso Central]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ankolekar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Geeganage]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Anderton]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hogg]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bath]]></surname>
<given-names><![CDATA[P.M.W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical trials for preventing post stroke cognitive impairment]]></article-title>
<source><![CDATA[Journal of the Neurological Sciences]]></source>
<year>2010</year>
<volume>299</volume>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<source><![CDATA[Anuario Estadístico de Salud]]></source>
<year>2015</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública de Cuba. Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<source><![CDATA[Anuario Estadístico de Salud]]></source>
<year>2016</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública de Cuba. Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<source><![CDATA[Anuario Estadístico de Salud]]></source>
<year>2017</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública de Cuba. Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<source><![CDATA[Anuario Estadístico de Salud]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública de Cuba. Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arruzazabala]]></surname>
<given-names><![CDATA[M.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Carbajal]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Noa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of policosanol on cerebral ischemia in Mongolian gerbils]]></article-title>
<source><![CDATA[Brazilian journal of medical and biological research]]></source>
<year>1999</year>
<volume>32</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1269-76</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Askarpour]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghaedi]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Roshanravan]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hadi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohammadi]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Symonds]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Miraghajani]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Policosanol supplementation significantly improves blood pressure among adults: A systematic review and meta-analysis of randomized controlled trials]]></article-title>
<source><![CDATA[Complementary Therapies in Medicine]]></source>
<year>2019</year>
<volume>45</volume>
<page-range>89-97</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Nombela]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez-Yanez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Gil]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Leira]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Davalos]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statin treatment withdrawal in ischemic stroke: a controlled randomized study]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2007</year>
<volume>69</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>904-10</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brian]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-Density Lipoprotein Modulates Glucose Metabolism in Patients with Type 2 Diabetes Mellitus]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2009</year>
<volume>119</volume>
<page-range>2103-11</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cervellati]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Trentini]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Romani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bellini]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Bosi]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Ortolani]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Zuliani]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum paraoxonase and aryl esterase activities of paraoxonase&#8208;1 (PON&#8208;1), mild cognitive impairment, and 2&#8208;year conversion to dementia: A pilot study]]></article-title>
<source><![CDATA[Journal of neurochemistry]]></source>
<year>2015</year>
<volume>135</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>395-401</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chambless]]></surname>
<given-names><![CDATA[L.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Heiss]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Shahar]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Earp]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Toole]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study]]></article-title>
<source><![CDATA[American Journal of Epidemiology]]></source>
<year>2004</year>
<volume>160</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>259-69</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Couillard]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Poppe]]></surname>
<given-names><![CDATA[A.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Coutts]]></surname>
<given-names><![CDATA[S.B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting recurrent stroke after minor stroke and transient ischemic attack]]></article-title>
<source><![CDATA[Expert Rev Cardiov Ther]]></source>
<year>2009</year>
<volume>100</volume>
<page-range>1273-81</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coull]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rothwell]]></surname>
<given-names><![CDATA[P.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[nderestimation of the early risk of recurrent stroke: evidence of the need for a standard definition]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2004</year>
<volume>35</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1925-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Desmond]]></surname>
<given-names><![CDATA[D.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Maroney]]></surname>
<given-names><![CDATA[J.T]]></given-names>
</name>
<name>
<surname><![CDATA[Paik]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Sano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mohr]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Aboumatar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency and Clinical determinats of dementia after ischemic Stroke]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2000</year>
<volume>54</volume>
<page-range>1124-31</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dichgans]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dementia risk after transient ischemic attack and stroke]]></article-title>
<source><![CDATA[The Lancet Neurology]]></source>
<year>2019</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>223-5</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drew]]></surname>
<given-names><![CDATA[B.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Formosa]]></surname>
<given-names><![CDATA[M.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Natoli]]></surname>
<given-names><![CDATA[A.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Henstridge]]></surname>
<given-names><![CDATA[D.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Penfold]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2009</year>
<volume>119</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>2103-11</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Illnait]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A preliminary retrospective analysis of the effects of policosanol on ischemic stroke patients]]></article-title>
<source><![CDATA[Int Res J Phar Med Sci]]></source>
<year>2019</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>28-34</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fidaleo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fanelli]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Paola Ceru]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPAR&#945;) and its lipid ligands]]></article-title>
<source><![CDATA[Current medicinal chemistry]]></source>
<year>2014</year>
<volume>21</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2803-21</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fraga]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Amor]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of policosanol on in vitro and in vivo rat liver microsomal lipid peroxidation]]></article-title>
<source><![CDATA[Archives of medical research]]></source>
<year>1997</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>355-3607</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ginneken]]></surname>
<given-names><![CDATA[V.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Meerveld]]></surname>
<given-names><![CDATA[A.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Verheij]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Greef]]></surname>
<given-names><![CDATA[J.V.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On the Futile Existence of DHA, None of EPA and the Predominant Role of the Triacylglycerols (TGs) in the Post Mortem Human Brain: An LCMS Study with Evolutionary Implications]]></article-title>
<source><![CDATA[J Bioanal Biomed]]></source>
<year>2017</year>
<volume>9</volume>
<page-range>152-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grilli]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramsay]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Minozzi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mass media interventions: effects on health services utilisation]]></article-title>
<source><![CDATA[Cochrane database of systematic reviews]]></source>
<year>2002</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Holtzman]]></surname>
<given-names><![CDATA[D.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mc Keel Jr]]></surname>
<given-names><![CDATA[D.W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry]]></article-title>
<source><![CDATA[Journal of Neurochemistry]]></source>
<year>2001</year>
<volume>77</volume>
<page-range>1168-80</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hillen]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Coshal]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Tilling]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Rudd]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[McGovern]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfe]]></surname>
<given-names><![CDATA[C.D.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Cause of Recurrence is multifactorial patterns, risk factors and outcomes of stroke recurrence in South London Stroke register]]></source>
<year>2019</year>
<publisher-name><![CDATA[Stroke]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Illnait]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Gámez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Estrella]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benefits of a long-term therapy with policosanol on hypercholesterolemic Elder patients: a controlled study]]></article-title>
<source><![CDATA[Int J Med Sci Currt Res]]></source>
<year>2019</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>383-95</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ionescu]]></surname>
<given-names><![CDATA[A M]]></given-names>
</name>
<name>
<surname><![CDATA[Carciumaru]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chirila]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sîrbu]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carotid atherosclerosis and lacunar stroke a possible association]]></article-title>
<source><![CDATA[Eur J of Pharm and Med Studies]]></source>
<year>2017</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-23</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[E.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[K.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects]]></article-title>
<source><![CDATA[International journal of molecular medicine]]></source>
<year>2017</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>889-99</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kontush]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HDL-mediated mechanisms of protection in cardiovascular disease]]></article-title>
<source><![CDATA[Cardiovascular research]]></source>
<year>2014</year>
<volume>103</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>341-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Alter]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Friday]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Sobel]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A multifactorial analysis of risk factors for recurrence of ischemic stroke]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>1994</year>
<volume>25</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>958-62</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Xue]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The associations of lipids and lipid ratios with stroke: A prospective cohort study]]></article-title>
<source><![CDATA[The Journal of Clinical Hypertension]]></source>
<year>2019</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>127-35</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lovett]]></surname>
<given-names><![CDATA[J.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Coull]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rothwell]]></surname>
<given-names><![CDATA[P.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<volume>62</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>569-73</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mandel]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sharf]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Berant]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Wanders]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Vreken]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Aviram]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells]]></article-title>
<source><![CDATA[Biochemical and biophysical research communications]]></source>
<year>1998</year>
<volume>250</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>369-73</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Policosanol]]></article-title>
<source><![CDATA[Drugs of the Future]]></source>
<year>2000</year>
<volume>25</volume>
<page-range>569-86</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mc Guinness]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Craig]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bullock]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Passmore]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statins for the prevention of dementia]]></article-title>
<source><![CDATA[Cochrane database of systematic reviews]]></source>
<year>2016</year>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Más]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Amor]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodeiro]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro]]></article-title>
<source><![CDATA[British journal of clinical pharmacology]]></source>
<year>2000</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-62</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mira Katan]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[MS Andreas Luft]]></surname>
<given-names><![CDATA[MD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Burden of Stroke]]></article-title>
<source><![CDATA[Semin Neurol]]></source>
<year>2018</year>
<volume>38</volume>
<page-range>208-11</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mortensen]]></surname>
<given-names><![CDATA[S.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Boushel]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-density lipoprotein: a new therapeutic target for glucose intolerance]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2013</year>
<volume>128</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2349-50</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norris]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[CZ]]></given-names>
</name>
<name>
<surname><![CDATA[Bornstein]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Chambers]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vascular risks of asymptomatic carotid stenosis]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>1991</year>
<volume>22</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1485-90</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paragh]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Balla]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Katona]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Seres]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Égerházi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Degrell]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia]]></article-title>
<source><![CDATA[European archives of psychiatry and clinical neuroscience]]></source>
<year>2002</year>
<volume>252</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>63-7</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pendlebury]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Rothwell]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2009</year>
<volume>8</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1006-18</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Illnait]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto a largo plazo del policosanol en la recuperación funcional de pacientes con ictus isquémico no cardioembólico: estudio de un año]]></article-title>
<source><![CDATA[Revista de Neurología]]></source>
<year>2017</year>
<volume>64</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>153-61</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Illnait]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of policosanol plus aspirin therapy on the neurological recovery and plasma oxidative markers of patients with ischemic stroke]]></article-title>
<source><![CDATA[J Pharm]]></source>
<year>2013</year>
<volume>3</volume>
<page-range>31-40</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of policosanol on patients with ischemic stroke with previous transient ischemic attack: a long- term follow-up]]></article-title>
<source><![CDATA[Rev CENIC. Cien Biol]]></source>
<year>2010</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-9</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-López]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Travieso]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Illnait-Ferrer]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Dorta]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Castaño]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas-Ferreiro]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes-Suarez]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of policosanol in the functional recovery of non-cardio embolic ischemic stroke hypertensive patients]]></article-title>
<source><![CDATA[Rev de Neurología]]></source>
<year>2018</year>
<volume>67</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>331-8</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Senanayake]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Goodenave]]></surname>
<given-names><![CDATA[D.B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?]]></article-title>
<source><![CDATA[Alzheimers Dement]]></source>
<year>2019</year>
<volume>5</volume>
<page-range>524-32</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[X.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sinclair]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasmalogens and Alzheimer&#8217;s disease: a review]]></article-title>
<source><![CDATA[Lipids Health Dis]]></source>
<year>2019</year>
<volume>18</volume>
<numero>100</numero>
<issue>100</issue>
</nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vance]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipoproteins secreted by cultured rat hepatocytes contain the antioxidant 1-alk-1-enyl-2-acylglycerophosphoethanolamine]]></article-title>
<source><![CDATA[Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism]]></source>
<year>1990</year>
<volume>1045</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>128-34</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sinclair]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasmalogens and Alzheimer&#8217;s disease: a review]]></article-title>
<source><![CDATA[Lipids in Health and Disease]]></source>
<year>2019</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[C.K.,]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Y.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[T.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[C.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis]]></article-title>
<source><![CDATA[Journal of Internal Medicine]]></source>
<year>2015</year>
<volume>277</volume>
<page-range>343-52</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zacharopoulou]]></surname>
<given-names><![CDATA[V.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Zacharopoulou]]></surname>
<given-names><![CDATA[G.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Karkoulias]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tsampalas]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Lazakidou]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atherosclerosis as a Risk Factor for Dementia and Alzheimer&#8217;s disease]]></article-title>
<source><![CDATA[Hellenic Journal &#959;f Atherosclerosis]]></source>
<year>2018</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarrouk]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Debbabi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bezine]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Karym]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Badreddine]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rouaud]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Hammami]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipid biomarkers in Alzheimer's disease]]></article-title>
<source><![CDATA[Current Alzheimer Research]]></source>
<year>2018</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>303-12</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zuaznábar]]></surname>
<given-names><![CDATA[M.A.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Concepción]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Marre]]></surname>
<given-names><![CDATA[G.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[R.M.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of cerebrovascular diseases in Cuba, 1970 to 2006]]></article-title>
<source><![CDATA[MEDICC review]]></source>
<year>2008</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>33-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
